Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone.

The researchers in this study used a cloned version of equine arteritis virus (EAV) to investigate the viral properties that influence how it is neutralised by the body’s immune response. They discovered that the GP5 protein on the surface of EAV is critical for neutralisation of the virus, and that mutations in this protein can affect the virus’s susceptibility to neutralisation.

Research Methodology

• First, the team utilised infectious cDNA clones of EAV and applied reverse genetics technology. This allowed them to manipulate the virus’s genetic composition to study specific aspects of its biology.
• They then generated a collection of 20 recombinant viruses, including ten chimeric viruses each containing the ORF5 (which codes for the GP5 protein) from different variants of EAV. These variants included laboratory, field, and vaccine strains.
• Additionally, they created a chimeric virus with the N-terminal ectodomain — the region of a membrane protein that sits outside the cell — of GP5 from a European strain of porcine reproductive and respiratory syndrome virus. They also made nine mutant EAVs with site-specific alterations in their GP5 proteins.

Findings

• The neutralization tendencies of each recombinant, chimeric, or mutant version of EAV was evaluated using EAV-centric monoclonal antibodies and EAV strain-specific polyclonal equine antisera.
• The data pointed out that GP5 ectodomain — the region of the GP5 protein outside of the virus — carries essential determinants for viral neutralization. This indicates that the GP5 protein plays a crucial role in how the immune system identifies and neutralizes EAV.
• Furthermore, it was discovered that the individual neutralization sites on GP5 are conformationally interactive, meaning they can change shape or structure in response to interactions with other molecules.
• The interchange between GP5 and the unglycosylated membrane protein product M was seen as likely elemental for the presentation of individual epitopes (parts of an antigen that antibodies or T cell receptors can bind to) in a neutralizing conformation — the structure that allows the immune system to neutralize the virus.
• Finally, switching particular amino acids within the GP5 ectodomain frequently led to differences in the neutralization behavior of the recombinant viruses. These differences mirrored the variations in neutralization tendencies seen in field strains of EAV, as well as those created during the continuous infection of EAV carrier stallions.